Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal DHEA for Vaginal Symptoms in Cancer Survivors
NCT01376349Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jul 2011
- Primary completion
- Aug 2013
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of dehydroepiandrosterone in vaginal atrophy, sponsored by Cancer and Leukemia Group B. Started Jul 2011; status: completed.
02
Drugs
dehydroepiandrosterone
03
Conditions
vaginal atrophy
Beyond the preview
Go deeper on NCT01376349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01376349.